AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Cheap Dividend Stocks to Buy. On April 8, Cantor Fitzgerald lowered its ...

With a market cap of $384.6 billion, AbbVie Inc. (ABBV) is a global research-driven pharmaceutical company that develops and ...

Shares of AbbVie Inc. ABBV rose 2.05% to $217.49 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.91% to 6,528.52 and the ...

AbbVie Inc. (ABBV) is positioned for growth recovery both in terms of profits and dividends. Upcoming FQ1 2026 earnings are ...

AbbVie Inc. (NYSE:ABBV) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On February 24, RBC Capital ...

AbbVie Inc (NYSE:ABBV) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail ...

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.

AbbVie Inc. remains well-positioned for long-term growth, despite recent share price consolidation. Learn more about ABBV ...

Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...

AbbVie Inc. signed an agreement with the US government to lower some drug prices and invest $100 billion domestically in exchange for an exemption from certain tariffs. The Trump administration has ...